Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine and Fluconazole for HAND
NCT01354314Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2010
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of paroxetine and fluconazole in HIV-associated neurocognitive disorder (HAND) (4 arms), sponsored by Johns Hopkins University. Primary endpoints: Change in CSF Ceramide (C18:0 Levels) at 24 weeks and Change in CSF 3-nitrosylated Protein Levels at 24 weeks. Started Nov 2010; status: completed.
02
Drugs
paroxetinefluconazole
03
Conditions
HIV-associated neurocognitive disorder (HAND)
Beyond the preview
Go deeper on NCT01354314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01354314.